- Home
- Publications
- Publication Search
- Publication Details
Title
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 9, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-11
DOI
10.1038/s41419-018-0968-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
- (2017) Audrey Laroche-Clary et al. Journal of Hematology & Oncology
- Reviving the guardian of the genome: Small molecule activators of p53
- (2017) Daniel Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas
- (2017) Audrey Laroche et al. Oncotarget
- Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System
- (2017) Stephen T. Hallett et al. Cell Reports
- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
- (2017) Hui Qin Wang et al. eLife
- Fortifying p53 – beyond Mdm2 inhibitors
- (2016) Anusha Sriraman et al. Aging-US
- Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex
- (2016) Casimiro Gerarduzzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53
- (2016) Magdalena Wienken et al. MOLECULAR CELL
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
- (2016) Anusha Sriraman et al. Oncotarget
- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas
- (2015) Antònia Obrador-Hevia et al. CANCER INVESTIGATION
- SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma
- (2015) K. L. J. Bill et al. CLINICAL CANCER RESEARCH
- Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
- (2015) M. Verreault et al. CLINICAL CANCER RESEARCH
- CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
- (2015) A-S Tigan et al. ONCOGENE
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways
- (2015) Anne Y. Saiki et al. Oncotarget
- CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
- (2015) Jorge Franco et al. Oncotarget
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
- (2014) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- New Roles of Cyclin D1
- (2013) Richard G. Pestell AMERICAN JOURNAL OF PATHOLOGY
- Correlation ofTP53andMDM2genotypes with response to therapy in sarcoma
- (2012) Hege O. Ohnstad et al. CANCER
- ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
- (2012) Mathew C. Casimiro et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Transcriptional role of cyclin D1 in development revealed by a genetic–proteomic screen
- (2010) Frédéric Bienvenu et al. NATURE
- Nutlin-3 Affects Expression and Function of Retinoblastoma Protein
- (2009) Wei Du et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas
- (2008) Antoine Italiano et al. CANCER LETTERS
- Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line
- (2007) Fredrik Persson et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started